# US 2025/0144429 A1 · Optimization of dbs program using a prespecified selection of contacts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144429 A1
- Document ID: US20250144429A1
- Status: Published application
- Kind: A1
- Application number: 18/934,118
- Filed: 2024-10-31
- Published: 2025-05-08
- Earliest claimed: 2023-11-02
- Assignees: Boston Scientific Neuromodulation Corporation
- Applicants: Boston Scientific Neuromodulation Corporation
- Inventors: Mahsa Malekmohammadi; Richard Mustakos; G. Karl Steinke
- Web page: https://patentgrep.com/patent/US20250144429A1

## CPC

- A61N 1/36185: {Selection of the electrode configuration}
- A61N 1/0534: {Electrodes for deep brain stimulation}
- A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease}
- A61N 1/36096: {Mood disorders, e.g. depression, anxiety or panic disorder}
- A61N 1/36135: {using physiological parameters}
- A61N 1/36139: {with automatic adjustment}
- A61N 1/3614: {based on impedance measurement}
- A61N 1/36142: {for improving safety}
- A61N 1/36157: {Current (A61N1/3616 takes precedence)}
- A61N 1/37247: {User interfaces, e.g. input or presentation means}
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 40/63: for local operation
- A61N 1/36062: {Spinal stimulation}
- A61N 1/36132: {using patient feedback}
- A61N 1/36182: {Direction of the electrical field, e.g. with sleeve around stimulating electrode}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Methods and systems for planning configurations of a neuromodulation system having a lead with a plurality of electrodes. Configurations are planned using an optimizer that analyzes potential fractionalizations after removing unavailable electrodes from analysis and adjusting a candidate fractionalization to account for the removed electrodes. The unavailable electrodes may be identified by a physician or by analysis of impedances of the electrodes.

## Claims

### Claim 1

A configuration system for configuring delivery of neuromodulation to specific tissue of a patient by an implantable system having a plurality of electrodes, the configuration system comprising:
a receiver module configured to receive at least patient data for a patient and lead position indicating a location of a lead carrying at least two of the plurality of electrodes thereon relative to neural tissue of the patient;
an optimizer for identifying candidate therapy parameter sets indicating utilization of the plurality of electrodes during therapy, the optimizer comprising:
a steering module for identifying a potential fractionalization to analyze, the potential fractionalization setting proportions of total current to be issued by each of the electrodes;
an electrode removal module that receives the potential fractionalization and removes unavailable electrodes from the potential fractionalization to generate a reduced fractionalization;
an adjusting module that receives the reduced fractionalization and creates an adjusted fractionalization;
a scoring module that receives the adjusted fractionalization and calculates a plurality of metrics for the adjusted fractionalization using a plurality of amplitude settings; and
a candidate module that identifies one or more candidate therapies using the plurality of metrics.

### Claim 2 (depends on 1)

The configuration system of claim 1, wherein the optimizer is configured to use the steering module to identify a plurality of potential fractionalizations.

### Claim 3 (depends on 1)

The configuration system of claim 1, wherein the potential fractionalization identifies active and inactive electrodes, and the adjusting module creates the adjusted fractionalization by proportionally increasing a fraction of current to be delivered by each active electrode which is not removed by the electrode removal module.

### Claim 4 (depends on 1)

The configuration system of claim 1, wherein the potential fractionalization identifies active and inactive electrodes, and the adjusting module modifies current fractionalization by adding current to active electrodes in proportion to proximity to the unavailable electrodes.

### Claim 5 (depends on 4)

The configuration system of claim 4, wherein the proportion is based on a Gaussian curve.

### Claim 6 (depends on 1)

The configuration system of claim 1, wherein the electrode removal module removes electrodes having an impedance outside of an impedance range.

### Claim 7 (depends on 1)

The configuration system of claim 1, wherein the electrode removal module removes electrodes that have been identified as unavailable by a physician.

### Claim 8 (depends on 7)

The configuration system of claim 7, wherein the electrode removal module is configured to identify an electrode that could be removed by identifying proximity to a neural structure less than a threshold proximity, and suggesting electrode removal to a physician via a user interface.

### Claim 9 (depends on 7)

The configuration system of claim 7, wherein the electrode removal module is configured to identify an electrode that could be removed by identifying an electrode having an impedance outside of an impedance range, and suggesting electrode removal to a physician via a user interface.

### Claim 10 (depends on 1)

The configuration system of claim 1, further comprising a voxel calculation module which identifies volumes located around the lead as voxels, and labels at least some voxels as target voxels to which therapy is to be directed.

### Claim 11 (depends on 10)

The configuration system of claim 10, wherein the voxel calculation module also labels at least some voxels as avoid voxels to which therapy is to be avoided.

### Claim 12 (depends on 10)

The configuration system of claim 10, wherein the scoring module calculates the plurality of metrics by determining which of the voxels would be activated by the adjusted fractionalization at a plurality of current amplitudes.

### Claim 13 (depends on 10)

The configuration system of claim 10, wherein the scoring module uses one or more of a weight for target voxels, a weight for avoid voxels, a weight for total activated voxels and/or a weight for total activated non-target and non-avoid voxels to calculate the metrics.

### Claim 14

A method of operation in a neuromodulation system, the neuromodulation system including an implantable system having a plurality of electrodes, and a configuration system configured to perform steps of the method, the method comprising:
a) receiving at least patient data for a patient and a lead position indicating a location of a lead carrying at least two of the plurality of electrodes thereon relative to neural tissue of the patient;
b) identifying a potential fractionalization to analyze, the potential fractionalization setting proportions of total current to be issued by each of the electrodes;
c) removing unavailable electrodes from the potential fractionalization to generate a reduced fractionalization;
d) adjusting the reduced fractionalization to create an adjusted fractionalization;
e) calculating a plurality of metrics for the adjusted fractionalization using a plurality of amplitude settings; and
identifying one or more of the adjusted fractionalizations as one or more candidate therapies using the plurality of metrics.

### Claim 15 (depends on 14)

The method of claim 14, further comprising communicating the one or more candidate therapies from the configuration system to a pulse generator for the implantable system, and activating the pulse generator to issue neuromodulation to the patient using at least one of the one or more candidate therapies.

### Claim 16 (depends on 14)

The method of claim 14, further comprising identifying a plurality of potential fractionalizations, and performing each of c), d) and e) for each of the plurality of potential fractionalizations.

### Claim 17 (depends on 14)

The method of claim 14, wherein the potential fractionalization identifies active and inactive electrodes, and step d) includes proportionally increasing a fraction of current to be delivered by each active electrode which is has not removed during step c).

### Claim 18 (depends on 14)

The method of claim 14, wherein the potential fractionalization identifies active and inactive electrodes, and step d) include increasing proportions of total current to be issued by each of the electrodes in proportion to proximity to the unavailable electrodes.

### Claim 19 (depends on 14)

The method of claim 14, wherein step c) includes removing electrodes having an impedance outside of an impedance range.

### Claim 20 (depends on 14)

The method of claim 14, wherein step c) includes removing electrodes that have been identified as unavailable by a physician.
